University of California San Francisco

Mohamed Abdelgadir Adam, MD

Mohamed Adam large headshot
Mohamed
Adam
MD

Assistant Professor of Surgery 
Division of Surgical Oncology

Address

550 16th Street, #6411
San Francisco, CA 94158
United States

Email: [email protected]

Biography

Mohamed Abdelgadir Adam is an assistant professor in the Division of Hepatobiliary and Pancreatic Surgery. He is a cancer surgeon who treats gastrointestinal tumors and specializes in the treatment of cancers of the pancreas and bile ducts. Dr. Adam has special expertise in robotic minimally invasive pancreato-biliary surgery, including robotic pancreaticoduodenectomy (Whipple procedure). Additionally, he has experience in regional treatment strategies for metastatic cancers in the liver and the peritoneal cavity, including placement of hepatic infusion pumps for patients with unresectable (colorectal and intrahepatic cholangiocarcinoma) liver disease and cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

 

Dr. Adam received his medical degree from the Faculty of Medicine and Health Sciences. He completed general surgery training at Duke University Medical Center in Durham, NC. He continued his training with a two-year fellowship in complex surgical oncology at the University of Pittsburgh Medical Center in Pittsburgh, PA. Dr. Adam also completed two research fellowships at Duke University.

 

Dr. Adam’s research focuses on leveraging translational artificial intelligence and machine learning algorithms to optimize cancer patients’ treatment. He is a prolific researcher and has already authored over one hundred publications. He is a member of several professional societies. Dr. Adam already received many academic honors at Duke University and UCSF.

Education

Education

MD: Faculty of Medicine and Health Sciences, Omdurman Islamic University, Sudan

Residencies

2018: General Surgery Residency, Duke University Medical Center

Fellowships
Complex General Surgical Oncology Fellowship
End Year
2020
Postdoctoral Training

2010: Postdoctoral Research Fellowship, Duke Institute for Genome Sciences & Policy, Durham, NC
2016: Research Fellowship, Duke Clinical Research Institute, Durham, NC

Board Certifications

American Board of Surgery, General Surgery

Clinical Expertise

Robotic Minimally Invasive Whipple & Distal Pancreatectomy
Bile Duct Cancer (Cholangiocarcinoma)
Bile Duct Injuries
Bile Duct Strictures
Transplantation
Choledochal Cysts
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Gallbladder Cancer
Gastrointestinal Carcinoid Tumor
Gastrointestinal Stromal Tumor (GIST)
Liver Cysts
Liver Metastases
Pancreatic Cancer
Pancreatic Cysts
Pancreatic Neuroendocrine Tumors
Stomach (Gastric) Cancer

Research Narrative

Dr. Adam’s research focuses on leveraging translational artificial intelligence and machine learning algorithms to optimize cancer staging and treatment. He is a prolific researcher and has already authored over one hundred publications.

Research Interests

Leveraging translational artificial intelligence and machine learning in optimizing staging and management of gastrointestinal cancers. 
Health Services Research

Research Pathways

Clinical Discovery & Health Services Research

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 22
  1. Systemic Therapy and Surgical Management of Peritoneal Mesothelioma.
    Nunez-Rocha RE, Kim AC, Adam M| | PubMed
  2. ASO Author Reflections: Innovative Robot-Assisted Endoluminal Resection for Gastroesophageal Junction Leiomyomas.
    Foroutani L, Ashraf Ganjouei A, Wang JJ, Aburayya BI, Corvera C, Alseidi A, Adam MA| | PubMed
  3. Robotic-Assisted Endoluminal Resection of Gastroesophageal Junction Leiomyoma with Transoral Specimen Extraction: Technique, Outcome, and Safety.
    Foroutani L, Ashraf Ganjouei A, Wang J, Aburayya BI, Corvera C, Alseidi A, Adam MA| | PubMed
  4. National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis.
    Casey M, Brown A, Romero-Hernandez F, Wang JJ, Ganjouei AA, Tozzi F, Rashidian N, Kirkwood K, Corvera C, Nakakura E, Alseidi A, Adam M| | PubMed
  5. Reply to: Letter to Editor Regarding Article "A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data" by Yang, Yanfei et al.
    Ashraf Ganjouei A, Wang J, Alseidi A, Adam MA| | PubMed
  6. ASO Visual Abstract: Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Data-Driven, Machine Learning Approach to Augment Clinical Judgement.
    Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM| | PubMed
  7. ASO Author Reflections: Machine Learning-Based Preoperative Prediction of Pancreatic Fistula after Pancreaticoduodenectomy.
    Ashraf Ganjouei A, Wang JJ, Romero-Hernandez F, Alseidi A, Adam MA| | PubMed
  8. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  9. ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms.
    Greenberg AL, Bartlett DL, Choudry HM, Adam MA| | PubMed
  10. Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment.
    Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM| | PubMed
  11. ASO Author Reflections: Contemporary Management Trends in Malignant Peritoneal Mesothelioma.
    Calthorpe L, Alseidi A, Adam MA| | PubMed
  12. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  13. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA| | PubMed
  14. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  15. Disparities in access to care among patients with appendiceal or colorectal cancer and peritoneal metastases: A medicare insurance-based study in the United States.
    Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Eng OS, Monson JRT, Ruff SM, Kasumova GG, Adam MO, Obeng-Gyasi S, Pawlik TM, Kim AC| | PubMed
  16. Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Tsung A, Adam MO, Pawlik TM, Kim AC| | PubMed
  17. Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma.
    Adam MA, Glencer A, AlMasri S, Winters S, Bahary N, Singhi A, Lee KK, Paniccia A, Zureikat AH| | PubMed
  18. ASO Author Reflections: Neoadjuvant Therapy for Nonpancreatic Periampullary Adenocarcinoma.
    Adam MA, Glencer AC, Zureikat AH| | PubMed
  19. ASO Author Reflections: An Objective Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy.
    Conroy PC, Alseidi A, Adam MA| | PubMed
  20. Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  21. ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
    Adam MA, Paniccia A| | PubMed
  22. Development of stability-indicating methods for cefquinome sulphate.
    Shantier SW, Gadkariem EA, Adam MO, Mohamed MA| | PubMed